Screening for breast cancer with mammography
暂无分享,去创建一个
[1] S. Shapiro,et al. The search for risk factors in breast cancer. , 1968, American journal of public health and the nation's health.
[2] S. Shapiro,et al. Periodic breast cancer screening in reducing mortality from breast cancer. , 1971, JAMA.
[3] S. Shapiro,et al. Evaluation of two contrasting types of screening programs. , 1973, Preventive medicine.
[4] S. Shapiro,et al. Lead time in breast cancer detection and implications for periodicity of screening. , 1974, American journal of epidemiology.
[5] P. Prorok,et al. Report of NCI Ad Hoc Pathology Working Group To Review the Gross and Microscopic Findings of Breast Cancer Cases in the HIP Study (Health Insurance Plan of Greater New York) , 1977 .
[6] S. Shapiro,et al. Evidence on screening for breast cancer from a randomized trial , 1977, Cancer.
[7] I. Andersson. Radiographic Screening for Breast Carcinoma , 1981, Acta radiologica: diagnosis.
[8] R. Doll,et al. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. , 1981, Journal of the National Cancer Institute.
[9] Description of method. Trial of early detection of breast cancer: description of method. , 1981, British Journal of Cancer.
[10] S. Shapiro,et al. Prospects for eliminating racial differences in breast cancer survival rates. , 1982, American journal of public health.
[11] A. Huggins,et al. The Edinburgh randomised trial of screening for breast cancer: description of method. , 1984, British Journal of Cancer.
[12] W. Odling-Smee,et al. Screening for Breast Cancer , 1985, The Lancet.
[13] S Shapiro,et al. Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening. , 1985, National Cancer Institute monograph.
[14] I S Simor,et al. Mammography in screening for breast cancer. , 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[15] J. Habbema,et al. Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study. , 1986, Journal of the National Cancer Institute.
[16] T. Landberg,et al. Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. , 1988, BMJ.
[17] I. Andersson,et al. [Screening with mammography--a critical attitude is supported by new findings]. , 1988, Lakartidningen.
[18] S. Shapiro. Determining the efficacy of breast cancer screening. , 1989, Cancer.
[19] L. Tabár,et al. The Swedish two county trial of mammographic screening for breast cancer: recent results and calculation of benefit. , 1989, Journal of epidemiology and community health.
[20] V. Rich. Personal communication , 1989, Nature.
[21] A. Miller,et al. Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequelae, 1963–1986 , 1989 .
[22] W. Hepburn,et al. Randomisation by cluster and the problem of social class bias. , 1989, Journal of epidemiology and community health.
[23] A. Huggins,et al. Edinburgh trial of screening for breast cancer: mortality at seven years , 1990, The Lancet.
[24] I. Gram,et al. Quality of life following a false positive mammogram. , 1990, British Journal of Cancer.
[25] S. Shapiro,et al. Evaluation of periodic breast cancer screening with mammography:mEthodology and early observations. 1966 , 1990, CA: a cancer journal for clinicians.
[26] L. Tabár,et al. Update of the Swedish two-county program of mammographic screening for breast cancer. , 1992, Radiologic clinics of North America.
[27] L. Tabár,et al. The Swedish two-county trial of mammographic screening for breast cancer: recent results on mortality and tumor characteristics. , 1992, Pathologie-biologie.
[28] P. Glasziou,et al. Meta-analysis adjusting for compliance: the example of screening for breast cancer. , 1992, Journal of clinical epidemiology.
[29] L. Tabár,et al. Breast cancer treatment and natural history: new insights from results of screening , 1992, The Lancet.
[30] S. Wall,et al. Breast cancer screening with mammography: overview of Swedish randomised trials , 1993, The Lancet.
[31] N. Wald,et al. Report of the European Society of Mastology Breast Cancer Screening Evaluation Committee * , 1993, Tumori.
[32] Michael C. Minnotte,et al. Noncancer deaths in white adult cancer patients. , 1993, Journal of the National Cancer Institute.
[33] B. Muir,et al. The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. , 1994, British Journal of Cancer.
[34] C. Smart. Highlights of the evidence of benefit for women aged 40–49 years from the 14‐year follow‐up of the breast cancer detection demonstration project , 1994, Cancer.
[35] S Shapiro,et al. Screening: Assessment of current studies , 1994, Cancer.
[36] P. Glasziou,et al. Mammographie screening trials for women aged under 50: A quality assessment and meta‐analysis , 1995 .
[37] L. Tabár,et al. Efficacy of breast cancer screening by age. New results swedish two‐county trial , 1995, Cancer.
[38] Ingvar Andersson,et al. An Overview of the Swedish Randomised Mammography Trials: Total Mortality Pattern and the Representivity of the Study Cohorts , 1996, Journal of medical screening.
[39] D. Benjamin. The efficacy of surgical treatment of breast cancer. , 1996, Medical hypotheses.
[40] B. Cox. Variation in the effectiveness of breast screening by year of follow-up. , 1997, Journal of the National Cancer Institute. Monographs.
[41] S. Shapiro,et al. Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan. , 1997, Journal of the National Cancer Institute. Monographs.
[42] H. Thornton. The voice of the breast cancer patient--a lonely cry in the wilderness. , 1997, European journal of cancer.
[43] P. Glasziou,et al. The quality and interpretation of mammographic screening trials for women ages 40-49. , 1997, Journal of the National Cancer Institute. Monographs.
[44] C J Baines,et al. The Gothenburg breast screening trial , 1997, Cancer.
[45] J. Elmore,et al. Ten-year risk of false positive screening mammograms and clinical breast examinations. , 1998, The New England journal of medicine.
[46] W. Hepburn,et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening , 1999, The Lancet.
[47] L. Tabár,et al. Primary and adjuvant therapy, prognostic factors and survival in 1053 breast cancers diagnosed in a trial of mammography screening. , 1999, Japanese journal of clinical oncology.
[48] S D Walter,et al. Meta-analysis of screening data: a survey of the literature. , 1999, Statistics in medicine.
[49] R W Blamey,et al. ABC of breast diseases: screening for breast cancer. , 2000, BMJ.
[50] Ary,et al. TEN-YEAR RISK OF FALSE POSITIVE SCREENING MAMMOGRAMS AND CLINICAL BREAST EXAMINATIONS , 2000 .
[51] Peter C Gøtzsche,et al. Is screening for breast cancer with mammography justifiable? , 2000, The Lancet.
[52] L. Tabár,et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. , 2000, Radiologic clinics of North America.
[53] L. Tabár,et al. Beyond randomized controlled trials , 2001, Cancer.
[54] O. Olsen,et al. Systematic review of screening for breast cancer with mammography , 2001 .
[55] A. Miller. Screening for breast cancer with mammography , 2001, The Lancet.
[56] J Austoker,et al. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance. , 2001, Journal of public health medicine.
[57] L. Tabár,et al. All-cause mortality among breast cancer patients in a screening trial: support for breast cancer mortality as an end point , 2002, Journal of medical screening.
[58] S. Duffy,et al. Are breast cancer screening programmes increasing rates of mastectomy? Observational study , 2002, BMJ : British Medical Journal.
[59] L. Tabár,et al. The mammographic screening trials: Commentary on the recent work by Olsen and Gøtzsche , 2002, Journal of surgical oncology.
[60] K. Cheng. Update on effects of screening mammography , 2002, The Lancet.
[61] Ingvar Andersson,et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials , 2002, The Lancet.
[62] I. Vejborg,et al. Early outcome of mammography screening in Copenhagen 1991–99 , 2002, Journal of medical screening.
[63] Evis Sala,et al. The Gothenburg Breast Screening Trial , 2003, Cancer.
[64] D. Torgerson,et al. Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals , 2003, BMJ : British Medical Journal.
[65] L. Tabár,et al. The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[66] L. Tabár,et al. Mammographic Screening: A Key Factor in the Control of Breast Cancer , 2003, Cancer journal.
[67] L. Tabár,et al. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening , 2003, The Lancet.
[68] M. Baum,et al. Mass breast screening: is there a hidden cost? , 2003 .
[69] I. Vejborg,et al. Breast cancer incidence after the start of mammography screening in Denmark , 2003, British Journal of Cancer.
[70] William A Hensel,et al. Mammographic screening for breast cancer. , 2003, The New England journal of medicine.
[71] E. Añorbe,et al. Screening Mammography [letter] , 2003 .
[72] G. Giles,et al. Evaluation of the organised mammographic screening programme in Australia. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[73] F. Berrino,et al. Women's perception of the benefits of mammography screening: population-based survey in four countries. , 2003, International journal of epidemiology.
[74] L. Rutqvist,et al. Followup after 11 years – update of mortality results in the Stockholm mammographic screening trial , 1997, Breast Cancer Research and Treatment.
[75] Floyd J Fowler,et al. Enthusiasm for cancer screening in the United States. , 2004, JAMA.
[76] Solveig Hofvind,et al. The cumulative risk of a false‐positive recall in the Norwegian Breast Cancer Screening Program , 2004, Cancer.
[77] Jan Mæhlen,et al. Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study , 2004, BMJ : British Medical Journal.
[78] S. Duffy,et al. Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern? , 2004, Journal of medical screening.
[79] Peter C Gøtzsche,et al. Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study , 2004, BMJ : British Medical Journal.
[80] G. Eklund,et al. Randomized study of mammography screening — preliminary report on mortality in the stockholm trial , 1991, Breast Cancer Research and Treatment.
[81] R. Peto,et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. , 2005, The Lancet. Oncology.
[82] G. Eklund,et al. The Stockholm breast cancer screening trial — 5-year results and stage at discovery , 2005, Breast Cancer Research and Treatment.
[83] S. Shapiro. The status of breast cancer screening: A quarter of a century of research , 2005, World Journal of Surgery.
[84] P. Gøtzsche,et al. Content of invitations for publicly funded screening mammography , 2006, BMJ : British Medical Journal.
[85] L. Nyström,et al. Breast cancer incidence and mortality in the Nordic capitals, 1970–1998. Trends related to mammography screening programmes , 2006, Acta oncologica.
[86] Sankey V. Williams,et al. Screening Mammography in Women 40 to 49 Years of Age: A Systematic Review for the American College of Physicians , 2007, Annals of Internal Medicine.
[87] I. Vejborg,et al. Predicting the risk of a false-positive test for women following a mammography screening programme , 2007, Journal of medical screening.